This product belongs to the 4-nitrogen steroid hormone compound, which is a specific type II 5α-reductase competitive inhibitor, inhibiting the conversion of peripheral testosterone into dihydrotestosterone, and reducing the level of dihydrotestosterone in blood, prostate, skin and other tissues. By reducing the level of dihydrotestosterone in blood and prostate tissue, it inhibits prostate hyperplasia and improves the related clinical symptoms of benign prostatic hyperplasia.

1. This product has a layered structure and non-uniform charge distribution, which can fix and inhibit viruses, bacteria and toxins produced in the digestive tract; it has the ability to cover the digestive tract mucosa, and by combining with mucus glycoproteins, it can repair and improve the defense function of the mucosal barrier against attacking factors in terms of both quality and quantity; 2. This product does not enter the blood circulation system, and is excreted from the body along with the fixed attacking factors with the peristalsis of the digestive tract itself. This product does not affect X-ray examination, does not change the color of stool, and does not change normal intestinal peristalsis.